These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37760559)

  • 1. Post-Chemoradiation Metastatic, Persistent and Resistant Nodes in Locally Advanced Rectal Cancer: Metrics and Their Impact on Long-Term Outcome.
    Calvo FA; Tudela M; Serrano J; Muñoz-Fernández M; Peligros MI; Garcia-Alfonso P; Del Valle E
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An International Multicenter Prospective Study Evaluating the Long-term Oncological Impact of Adjuvant Chemotherapy in ypN+ Rectal Cancer.
    Denost Q; Fleming CA; Burghgraef T; Celerier B; Geitenbeek R; Rullier E; Tuynman J; Consten E; Hompes R;
    Ann Surg; 2023 Feb; 277(2):299-304. PubMed ID: 36305301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of nodal involvement in rectal cancer after chemoradiotherapy.
    Haak HE; Beets GL; Peeters K; Nelemans PJ; Valentini V; Rödel C; Kuo L; Calvo FA; Garcia-Aguilar J; Glynne-Jones R; Pucciarelli S; Suarez J; Theodoropoulos G; Biondo S; Lambregts DMJ; Beets-Tan RGH; Maas M
    Br J Surg; 2021 Oct; 108(10):1251-1258. PubMed ID: 34240110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
    Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study.
    Chen P; Yao Y; Gu J
    Int J Colorectal Dis; 2015 Dec; 30(12):1695-704. PubMed ID: 26278877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer.
    Kim NK; Kim YW; Min BS; Lee KY; Sohn SK; Cho CH
    World J Surg; 2009 Aug; 33(8):1741-9. PubMed ID: 19495867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
    Petrucciani N; Carra MC; Martínez-Pérez A; Vitali GC; Landi F; Genova P; Memeo R; Brunetti F; Espin E; Ris F; De'angelis N;
    Anticancer Res; 2019 Apr; 39(4):2113-2120. PubMed ID: 30952757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
    Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).
    Yeo SG; Kim DY; Kim TH; Chang HJ; Oh JH; Park W; Choi DH; Nam H; Kim JS; Cho MJ; Kim JH; Park JH; Kang MK; Koom WS; Kim JS; Nam TK; Chie EK; Kim JS; Lee KJ
    Ann Surg; 2010 Dec; 252(6):998-1004. PubMed ID: 21107110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer.
    Jayaprakasam VS; Paroder V; Gibbs P; Bajwa R; Gangai N; Sosa RE; Petkovska I; Golia Pernicka JS; Fuqua JL; Bates DDB; Weiser MR; Cercek A; Gollub MJ
    Eur Radiol; 2022 Feb; 32(2):971-980. PubMed ID: 34327580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of pathological node status after neoadjuvant radiotherapy for rectal cancer.
    Duchalais E; Glyn Mullaney T; Spears GM; Kelley SR; Mathis K; Harmsen WS; Larson DW
    Br J Surg; 2018 Oct; 105(11):1501-1509. PubMed ID: 29663352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
    De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
    Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
    Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
    Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
    Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
    Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for low rectal cancer patients undergoing intersphincteric resection after neoadjuvant chemoradiation.
    Lee SY; Jo JS; Kim HJ; Kim CH; Kim YJ; Kim HR
    J Surg Oncol; 2015 Jun; 111(8):1054-8. PubMed ID: 25977149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically Node Negative, Pathologically Node Positive Rectal Cancer Patients Who Did Not Receive Neoadjuvant Therapy.
    Akeel N; Lan N; Stocchi L; Costedio MM; Dietz DW; Gorgun E; Kalady MF; Karagkounis G; Kessler H; Remzi FH
    J Gastrointest Surg; 2017 Jan; 21(1):49-55. PubMed ID: 27796635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.